Overview
EnQuest PLC is a UK-based independent oil and gas production company focused on the extraction and management of hydrocarbon resources. EnQuest's primary operations are concentrated in the UK North Sea, where it is involved in the production of mature oil fields.
Basic Stats
The share price of EnQuest PLC as of June 10, 2024 is $0.19 / share.
The Factor Analysis chart (below right) shows a view of EnQuest PLC from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 0.00 MM |
| Earnings Date | |
| EPS (TTM) | |
| Dividend Yield | |
| Ex-Dividend Date | 2025-05-01 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.03 |
| ROE | 0.19 |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for EnQuest PLC is $0.17. The forecasts range from a low of $0.14 to a high of $0.21. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for EnQuest PLC. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2016-02-09 | Barclays | Underweight | Reiterate | |
| 2016-02-02 | Liberum Capital | Sell | Reiterate | |
| 2016-01-08 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-12-10 | Canaccord Genuity | Hold | Reiterate | |
| 2015-11-18 | Numis | Buy | Reiterate | |
| 2015-11-10 | Barclays | Underweight | Reiterate | |
| 2015-10-08 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-08-20 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-05-26 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-05-20 | Canaccord Genuity | Buy | Reiterate | |
| 2015-05-15 | Westhouse Securities | Buy | Reiterate | |
| 2015-04-10 | Westhouse Securities | Buy | Reiterate | |
| 2015-03-20 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-03-19 | Westhouse Securities | Buy | Reiterate | |
| 2015-02-02 | Westhouse Securities | Buy | Reiterate | |
| 2015-01-30 | Credit Suisse | Outperform | Reiterate | |
| 2015-01-23 | Westhouse Securities | Buy | Reiterate | |
| 2014-12-04 | Canaccord Genuity | Hold | Reiterate | |
| 2014-12-02 | Numis Securities | Buy | Reiterate | |
| 2014-12-01 | Westhouse Securities | Buy | Reiterate | |
| 2014-12-01 | Credit Suisse | Outperform | Reiterate | |
| 2014-11-13 | Canaccord Genuity | Hold | Reiterate | |
| 2014-11-13 | Numis Securities | Buy | Reiterate | |
| 2014-11-13 | Barclays | Underweight | Reiterate | |
| 2014-11-12 | Westhouse Securities | Neutral | Reiterate | |
| 2024-07-10 | Canaccord Genuity | Speculative Buy | Reiterate | |
| 2023-09-12 | Barclays | Equal Weight | Reiterate | |
| 2023-04-17 | Canaccord Genuity | Speculative Buy | Reiterate | |
| 2023-01-26 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-11-18 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-11-18 | Barclays | Underweight | Reiterate | |
| 2022-10-07 | Barclays | Underweight | Reiterate | |
| 2022-09-20 | Barclays | Underweight | Reiterate | |
| 2022-09-08 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-08-24 | Barclays | Underweight | Reiterate | |
| 2022-08-03 | Barclays | Underweight | Reiterate | |
| 2022-07-15 | Barclays | Underweight | Reiterate | |
| 2022-04-07 | Canaccord Genuity | Speculative Buy | Reiterate | |
| 2022-04-06 | Barclays | Equal Weight | Reiterate | |
| 2022-03-24 | Barclays | Equal Weight | Reiterate | |
| 2022-03-11 | Barclays | Equal Weight | Reiterate | |
| 2022-02-24 | Barclays | Equal Weight | Reiterate | |
| 2022-02-24 | Barclays | Reiteration | Reiterate | |
| 2022-01-14 | Barclays | Reiteration | Reiterate | |
| 2022-01-11 | Canaccord Genuity | Reiteration | Reiterate | |
| 2021-11-18 | Barclays | Reiteration | Reiterate | |
| 2021-10-13 | Canaccord Genuity | Speculative Buy | Reiterate | |
| 2021-10-08 | Barclays | Overweight | Reiterate | |
| 2021-09-03 | Barclays | Overweight | Reiterate | |
| 2021-03-31 | Canaccord Genuity | Hold | Reiterate | |
| 2021-02-11 | Barclays | Equal-weight | Initiate | |
| 2019-10-15 | Canaccord Genuity | Hold | Reiterate | |
| 2019-06-24 | Barclays | Underweight | Reiterate | |
| 2019-04-09 | Canaccord Genuity | Hold | Reiterate | |
| 2019-02-25 | Canaccord Genuity | Hold | Reiterate | |
| 2019-02-11 | Barclays | Underweight | Reiterate | |
| 2018-07-12 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2018-03-26 | Canaccord Genuity | Hold | Reiterate | |
| 2017-09-08 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2017-04-11 | Barclays | Underweight | Reiterate | |
| 2017-03-23 | Barclays | Underweight | Reiterate | |
| 2017-02-09 | Barclays | Underweight | Reiterate | |
| 2017-02-06 | Citigroup | Sell | Reiterate | |
| 2017-01-25 | Barclays | Underweight | Reiterate | |
| 2017-01-10 | Barclays | Underweight | Reiterate | |
| 2017-01-03 | Barclays | Overweight | Reiterate | |
| 2016-12-06 | Canaccord Genuity | Hold | Reiterate | |
| 2016-11-22 | Barclays | Overweight | Reiterate | |
| 2016-11-14 | UBS | Buy | Reiterate | |
| 2016-10-14 | Jefferies | Hold | Reiterate | |
| 2016-09-12 | Canaccord Genuity | Hold | Reiterate | |
| 2016-09-09 | Macquarie | Outperform | Reiterate | |
| 2016-09-09 | UBS | Buy | Reiterate | |
| 2016-08-31 | Canaccord Genuity | Hold | Reiterate | |
| 2016-05-24 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-04-25 | Barclays | Underweight | Reiterate | |
| 2016-04-07 | Jefferies | Hold | Reiterate | |
| 2016-03-30 | UBS | Neutral | Reiterate | |
| 2016-03-18 | Canaccord Genuity | Hold | Reiterate | |
| 2016-03-18 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-03-14 | Jefferies | Hold | Reiterate | |
| 2016-02-26 | UBS | Neutral | Reiterate | |
| 2016-02-23 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2013-08-14 | Morgan Stanley | Underweight | Reiterate | |
| 2013-08-13 | Westhouse Securities | Neutral | Reiterate | |
| 2013-08-06 | RBC Capital Markets | Neutral | Reiterate | |
| 2013-07-08 | Morgan Stanley | Underweight | Reiterate | |
| 2013-06-21 | Jefferies | Buy | Reiterate | |
| 2014-11-06 | Liberum Capital | Buy | Reiterate | |
| 2014-11-03 | Numis Securities | Buy | Reiterate | |
| 2014-10-28 | Credit Suisse | Outperform | Reiterate | |
| 2014-10-16 | Numis Securities | Buy | Reiterate | |
| 2014-10-14 | Credit Suisse | Outperform | Reiterate | |
| 2014-10-14 | Liberum Capital | Buy | Reiterate | |
| 2014-10-06 | Credit Suisse | Outperform | Reiterate | |
| 2014-10-01 | Numis Securities | Buy | Reiterate | |
| 2014-10-01 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-09-22 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-09-11 | Numis Securities | Buy | Reiterate | |
| 2014-09-02 | Canaccord Genuity | Buy | Reiterate | |
| 2014-08-19 | Credit Suisse | Outperform | Reiterate | |
| 2014-08-14 | UBS | Neutral | Reiterate | |
| 2014-08-13 | Liberum Capital | Buy | Reiterate | |
| 2014-08-13 | Westhouse Securities | Neutral | Reiterate | |
| 2014-08-11 | Credit Suisse | Outperform | Reiterate | |
| 2014-07-28 | Credit Suisse | Outperform | Reiterate | |
| 2014-07-24 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-07-23 | Canaccord Genuity | Buy | Reiterate | |
| 2014-06-25 | UBS | Neutral | Reiterate | |
| 2014-06-13 | Westhouse Securities | Neutral | Reiterate | |
| 2014-05-30 | Canaccord Genuity | Buy | Reiterate | |
| 2014-05-21 | Credit Suisse | Outperform | Reiterate | |
| 2014-04-15 | BMO | Neutral | Initiate | |
| 2014-04-08 | Numis Securities | Buy | Reiterate | |
| 2014-04-02 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-04-01 | HSBC | Overweight | Reiterate | |
| 2014-03-27 | Canaccord Genuity | Buy | Reiterate | |
| 2014-03-10 | Credit Suisse | Outperform | Reiterate | |
| 2014-03-05 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-03-03 | Westhouse Securities | Neutral | Reiterate | |
| 2014-02-25 | Barclays | Underweight | Reiterate | |
| 2014-02-05 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2014-01-27 | Liberum Capital | Buy | Reiterate | |
| 2014-01-24 | Morgan Stanley | Underweight | Reiterate | |
| 2014-01-16 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-12-11 | Goldman Sachs | Neutral | Reiterate | |
| 2013-12-03 | Canaccord Genuity | Buy | Reiterate | |
| 2013-11-20 | Liberum Capital | Buy | Reiterate | |
| 2013-11-14 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-10-22 | Westhouse Securities | Neutral | Reiterate | |
| 2013-09-13 | Numis Securities | Buy | Reiterate | |
| 2013-08-14 | Canaccord Genuity | Buy | Reiterate | |
| 2013-08-14 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2025-07-15 | Shore Capital | Buy | Initiate | |
| 2024-09-12 | Canaccord Genuity | Buy | Reiterate | |
| 2025-07-25 | Shore Capital | Buy | Reiterate | |
| 2025-03-31 | Canaccord Genuity | Buy | Reiterate | |
| 2025-08-19 | Shore Capital | Buy | Reiterate |
